WKL.AS

Wolters Kluwer N.V. [WKL.AS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

WKL.AS Stock Summary

Earnings have grown 14.29% per last year.

EPS has been increasing for the past 3 years (Yearly statements)

WKL.AS's dividend payments are well covered by cash flows with cash payout ratio of 63.48%.

Earnings are expected to fall -5.84% next year

WKL.AS's dividend payments have fallen since the beginning of the year

WKL.AS has less than 1 year of cash runway

Debt-to-Equity ratio of 1.79 is considered moderate, deeper research suggested.

Top 10 Correlated ETFs

WKL.AS

Top 10 Correlated Stocks

WKL.AS

In the News

WKL.AS Financial details

Company Rating

Strong Buy

Market Cap

27.77B

Income

728M

Revenue

4.77B

Book val./share

Cash/share

Dividend

1.9

Dividend %

1.65%

Employees

20.92K

Optionable

Shortable

Yes

Earnings

02 Aug 2023

P/E

28.51

Forward P/E

31.05

PEG

795.43

P/S

5.13

P/B

12.67

P/C

P/FCF

21.72

Quick Ratio

0.35

Current Ratio

0.77

Debt / Equity

1.79

LT Debt / Equity

1.54

EPS (TTM)

2.8

EPS next Y

3.71

EPS next Q

EPS this Y

44.44%

EPS next Y

32.68%

EPS next 5Y

32.68%

EPS last 5Y

11.2%

Revenue last 5Y

5.06%

Revenue Q/Q

EPS Q/Q

SMA20

3.67%

SMA50

1.82%

SMA100

3.52%

Inst Own

Inst Trans

ROA

11%

ROE

43%

ROC

0.24%

Gross Margin

71%

Oper. Margin

24%

Profit Margin

19%

Payout

41%

Shs Outstand

243.22M

Shs Float

245.19M

Target Price

52W Range

96.08-123.35

52W High

-6.34%

52W Low

+20%

RSI

56.34

Rel Volume

0.04

Avg Volume

410.71K

Volume

14.86K

Perf Week

-1.2%

Perf Month

5.59%

Perf Quarter

-4.95%

Perf Half Y

1.54%

Beta

0.331081

Volatility

0.78%, 2.61%

Prev Close

1.19%

Price

115.2

Change

1.27%

WKL.AS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31
Revenue per share	15.4	17.06	17.37	18.32	21.41
Net income per share	2.37	2.48	2.72	2.8	4.03
Operating cash flow per share	3.38	4.08	4.52	4.96	6.21
Free cash flow per share	2.6	3.24	3.62	4.04	5.05
Cash per share	2.83	3.33	2.73	3.84	5.28
Book value per share	8.19	8.81	7.88	9.28	9.07
Tangible book value per share	-12.71	-12.26	-13.4	-12.99	-14.65
Share holders equity per share	8.19	8.81	7.88	9.28	9.07
Interest debt per share	10.4	11.74	11.97	12.26	14.42
Market cap	14.29B	17.57B	18.3B	26.98B	24.9B
Enterprise value	16.32B	19.78B	20.68B	29.11B	27.17B
P/E ratio	21.76	26.27	25.38	37.06	24.24
Price to sales ratio	3.36	3.81	3.98	5.65	4.57
POCF ratio	15.3	15.95	15.29	20.88	15.74
PFCF ratio	19.85	20.06	19.08	25.64	19.35
P/B Ratio	6.31	7.38	8.77	11.16	10.78
PTB ratio	6.31	7.38	8.77	11.16	10.78
EV to sales	3.83	4.29	4.49	6.1	4.98
Enterprise value over EBITDA	13.56	14.7	14.34	20.07	15.99
EV to operating cash flow	17.47	17.95	17.27	22.53	17.17
EV to free cash flow	22.67	22.58	21.56	27.67	21.11
Earnings yield	0.05	0.04	0.04	0.03	0.04
Free cash flow yield	0.05	0.05	0.05	0.04	0.05
Debt to equity	1.24	1.31	1.48	1.29	1.56
Debt to assets	0.34	0.35	0.37	0.35	0.38
Net debt to EBITDA	1.68	1.64	1.65	1.47	1.34
Current ratio	0.68	0.65	0.69	0.9	0.77
Interest coverage	13.73	13.55	13.14	15.81	23.39
Income quality	1.42	1.65	1.66	1.77	1.54
Dividend Yield	0.02	0.02	0.02	0.01	0.02
Payout ratio	0.42	0.42	0.46	0.51	0.41
Sales general and administrative to revenue	0.19	0.19	0.2	0.19	0.18
Research and developement to revenue	0.1	0.1	0.09	0.1	0.1
Intangibles to total assets	0.69	0.65	0.67	0.64	0.64
Capex to operating cash flow	-0.23	-0.21	-0.2	-0.19	-0.19
Capex to revenue	-0.05	-0.05	-0.05	-0.05	-0.05
Capex to depreciation	-0.56	-0.54	-0.56	-0.57	-0.68
Stock based compensation to revenue	0.01	0.01	0.01	0.01	0.01
Graham number	20.92	22.14	21.96	24.16	28.68
ROIC	0.14	0.12	0.14	0.13	0.17
Return on tangible assets	0.26	0.22	0.26	0.23	0.3
Graham Net	-18.95	-20.2	-20.9	-21.42	-22.83
Working capital	-1.07B	-1.33B	-968M	-318M	-892M
Tangible asset value	-3.52B	-3.31B	-3.55B	-3.38B	-3.73B
Net current asset value	-3.79B	-3.92B	-4.11B	-3.87B	-4.22B
Invested capital	1.24	1.31	1.48	1.29	1.56
Average receivables	0	0	0	0	0
Average payables	366M	283M	151M	128M	135M
Average inventory	85M	74M	70.5M	66.5M	72M
Days sales outstanding	0	0	0	0	0
Days payables outstanding	111.72	44.54	35.72	32.67	34
Days of inventory on hand	21.11	19.24	18.26	17.27	18.27
Receivables turnover	0	0	0	0	0
Payables turnover	3.27	8.2	10.22	11.17	10.73
Inventory turnover	17.29	18.97	19.99	21.14	19.97
ROE	0.29	0.28	0.35	0.3	0.44
Capex per share	-0.77	-0.84	-0.9	-0.92	-1.16

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric	2021-09-30	2021-12-31	2022-06-30	2022-12-31	2023-06-30
Revenue per share	4.58	4.58	0	0	0
Net income per share	0.7	0.7	0	0	0
Operating cash flow per share	1.24	1.24	0	0	0
Free cash flow per share	1.01	1.01	0	0	0
Cash per share	0.96	3.84	0	0	0
Book value per share	2.32	9.28	0	0	0
Tangible book value per share	-3.25	-12.99	0	0	0
Share holders equity per share	2.32	9.28	0	0	0
Interest debt per share	2.74	12.08	0	0	0
Market cap	23.85B	26.98B	0	0	0
Enterprise value	24.38B	29.11B	2.2B	2.27B	2.47B
P/E ratio	32.76	37.06	0	0	0
Price to sales ratio	19.99	22.62	0	0	0
POCF ratio	73.83	83.52	0	0	0
PFCF ratio	90.67	102.58	0	0	0
P/B Ratio	39.47	11.16	0	0	0
PTB ratio	39.47	11.16	0	0	0
EV to sales	20.44	24.4	0	0	0
Enterprise value over EBITDA	67.25	80.29	0	0	0
EV to operating cash flow	75.48	90.11	0	0	0
EV to free cash flow	92.7	110.67	0	0	0
Earnings yield	0.01	0.01	0	0	0
Free cash flow yield	0.01	0.01	0	0	0
Debt to equity	1.15	1.29	1.25	1.56	1.79
Debt to assets	0.31	0.35	0.35	0.38	0.39
Net debt to EBITDA	1.47	5.87	0	0	0
Current ratio	0.9	0.9	0.71	0.77	0.75
Interest coverage	16.27	20.09	0	0	0
Income quality	1.77	1.77	0	0	0
Dividend Yield	0	0	0	0	0
Payout ratio	0.51	0.51	0	0	0
Sales general and administrative to revenue	0.36	0.36	0	0	0
Research and developement to revenue	0.1	0.1	0	0	0
Intangibles to total assets	0.64	0.64	0.65	0.64	0.66
Capex to operating cash flow	-0.19	-0.19	0	0	0
Capex to revenue	-0.05	-0.05	0	0	0
Capex to depreciation	-0.57	-0.57	0	0	0
Stock based compensation to revenue	0.01	0.01	0	0	0
Graham number	6.04	12.08	0	0	0
ROIC	0.16	0.04	0	0	0
Return on tangible assets	0.23	0.06	0	0	0
Graham Net	-5.35	-21.42	0	0	0
Working capital	-79.5M	-318M	-1.14B	-892M	-865M
Tangible asset value	-845.75M	-3.38B	-3.48B	-3.73B	-3.98B
Net current asset value	-968.25M	-3.87B	-4B	-4.22B	-4.43B
Invested capital	1.15	1.29	1.25	1.56	1.79
Average receivables	0	0	0	0	0
Average payables	381.88M	76.88M	0	0	0
Average inventory	43.63M	40.63M	0	0	0
Days sales outstanding	0	0	0	0	0
Days payables outstanding	8.06	32.23	0	0	0
Days of inventory on hand	4.26	17.03	0	0	0
Receivables turnover	0	0	0	0	0
Payables turnover	11.17	2.79	0	0	0
Inventory turnover	21.14	5.28	0	0	0
ROE	0.3	0.08	0	0	0
Capex per share	-0.23	-0.23	0	0	0

WKL.AS Dividend History

WKL.AS Frequently Asked Questions

What is Wolters Kluwer N.V. stock symbol ?

Wolters Kluwer N.V. is a NL stock and trading under the symbol WKL.AS

What is Wolters Kluwer N.V. stock quote today ?

Wolters Kluwer N.V. stock price is $115.2 today.

Is Wolters Kluwer N.V. stock public?

Yes, Wolters Kluwer N.V. is a publicly traded company.

Something similar

Top by Market Cap

Company Profile

Volume Average 410.71K
Market Capitalization 27.77B
Employee 20.92K
CEO Ms. Nancy McKinstry
Headquarters Alphen aan den Rijn,NL
IPO Date 1995-03-29
Website https://wolterskluwer.com

Wolters Kluwer N.V. provides professional information, software solutions, and services in the Netherlands, rest of Europe, the United States, Canada, the Asia Pacific, and internationally. The company operates through four segments: Health; Tax & Accounting; Governance, Risk & Compliance; and Legal & Regulatory. The Health segment offers clinical technology and evidence-based solutions that drive effective decision-making and improved outcomes across healthcare. It provides solutions for hospitals, clinics, other healthcare providers, individual clinicians and students, nursing and medical schools and libraries, retail pharmacies, payers, and life sciences organizations. The Tax & Accounting segment offers solutions that help tax, accounting, and audit professionals to drive productivity, navigate change, and deliver better outcomes. It provides solutions for accounting firms, corporate finance, tax and auditing departments, government agencies, libraries, and universities. The Governance, Risk & Compliance segment offers technology-enabled services and solutions for legal entity compliance, legal operations management, banking product compliance, and regulatory reporting. It serves legal, compliance, and risk professionals in corporations, small businesses, law firms, insurers, banks, non-bank lenders, credit unions, leasing companies, and securities firms. The Legal & Regulatory segment provides evidence-based information, actionable insights, and integrated workflow solutions that help customers to make the right decisions and streamline compliance. It enables legal and compliance professionals, and operational risk managers, as well as environmental, health, and safety managers to improve productivity and performance, mitigate risk, and solve complex problems with confidence in law firms, corporations, universities, and government agencies. Wolters Kluwer N.V. was founded in 1836 and is based in Alphen aan den Rijn, the Netherlands.